Glenmark Pharma receives USFDA approval for Chlorpromazine Hydrochloride tablets

Glenmark is the first approved applicant for such competitive generic therapy and is eligible for 180 days of CGT exclusivity upon commercial marketing.

from India Infoline News Service https://ift.tt/31curJn